Monday, June 15, 2026

Unlocking Global Biotech: CGB-CIC Innovation Center Launching in 2026

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.

Misuse of subsidies uncovered in North Korea human rights projects, including spending at bars

Improper use of government subsidies for North Korea human rights projects raises calls for stricter oversight and transparency measures.

UN Special Rapporteur on North Korean Human Rights, Elizabeth Salmon, Visits South Korea: What to Expect?

UN Special Rapporteur Elizabeth Salmon will visit South Korea to assess North Korean human rights from February 2 to 6, 2024.

Tag: orforglipron

Eli Lilly’s Oral GLP-1 Shows 7.9% Weight Loss in Type 2 Diabetes Trial

Eli Lilly's orforglipron shows promise in Phase 3 trials for diabetes and obesity, offering an oral alternative to injectables.

Top News

- Our Sponsors Ad -

Follow us